The global stable isotope labeled biomolecules market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The market is driven by the increasing demand for stable isotope labeled biomolecules in scientific research and medical applications, which are expected to drive the growth of this market over the next few years. D Labeled Biomolecules segment accounted for the largest share of this market in 2018 and is expected to continue its dominance throughout the forecast period due to their wide range of applications in various industries such as pharmaceuticals, food & beverage, agriculture, and others. North America was estimated as one of the leading regions for this type of product in 2018 due to its high adoption rates among various industries such as pharmaceuticals and food & beverage industry.
Some Of The Growth Factors Of This Market:
- The increasing demand for food and beverages is expected to drive the market growth.
- The increasing awareness about the benefits of using stable isotope labeled biomolecules in research and development is expected to drive the market growth.
- The increasing number of clinical trials for various diseases is expected to drive the market growth.
- The growing need for accurate diagnosis and treatment of various diseases is expected to drive the market growth.
- Increasing government funding for research and development activities related to stable isotope labeled biomolecules is expected to fuel the market growth.
Industry Growth Insights published a new data on “Stable Isotope Labeled Biomolecules Market”. The research report is titled “Stable Isotope Labeled Biomolecules Market research by Types (D Labeled Biomolecules, 15N Labeled Biomolecules, 13C Labeled Biomolecules, Others, ), By Applications (Scientific Research, Medical, Industrial, Others, ), By Players/Companies Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife, WITEGA Laboratorien, Omicron Biochemicals, Icon Isotopes, Medical Isotopes”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stable Isotope Labeled Biomolecules Market Research Report
By Type
D Labeled Biomolecules, 15N Labeled Biomolecules, 13C Labeled Biomolecules, Others,
By Application
Scientific Research, Medical, Industrial, Others,
By Companies
Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife, WITEGA Laboratorien, Omicron Biochemicals, Icon Isotopes, Medical Isotopes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Stable Isotope Labeled Biomolecules Market Report Segments:
The global Stable Isotope Labeled Biomolecules market is segmented on the basis of:
Types
D Labeled Biomolecules, 15N Labeled Biomolecules, 13C Labeled Biomolecules, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Scientific Research, Medical, Industrial, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cambridge Isotope Laboratories
- Sigma-Aldrich
- Thermo Fisher Scientific
- LGC Standards
- Toronto Research Chemicals
- IsoLife
- WITEGA Laboratorien
- Omicron Biochemicals
- Icon Isotopes
- Medical Isotopes
Highlights of The Stable Isotope Labeled Biomolecules Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- D Labeled Biomolecules
- 15N Labeled Biomolecules
- 13C Labeled Biomolecules
- Others
- By Application:
- Scientific Research
- Medical
- Industrial
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stable Isotope Labeled Biomolecules Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stable isotope labeled biomolecules are molecules that have been tagged with a stable isotope of an element. This allows scientists to track the molecule's movements and interactions in detail.
Some of the key players operating in the stable isotope labeled biomolecules market are Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife, WITEGA Laboratorien, Omicron Biochemicals, Icon Isotopes, Medical Isotopes.
The stable isotope labeled biomolecules market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stable Isotope Labeled Biomolecules Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Stable Isotope Labeled Biomolecules Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Stable Isotope Labeled Biomolecules Market - Supply Chain
4.5. Global Stable Isotope Labeled Biomolecules Market Forecast
4.5.1. Stable Isotope Labeled Biomolecules Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Stable Isotope Labeled Biomolecules Market Size (000 Units) and Y-o-Y Growth
4.5.3. Stable Isotope Labeled Biomolecules Market Absolute $ Opportunity
5. Global Stable Isotope Labeled Biomolecules Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Type
5.3.1. D Labeled Biomolecules
5.3.2. 15N Labeled Biomolecules
5.3.3. 13C Labeled Biomolecules
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Stable Isotope Labeled Biomolecules Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Application
6.3.1. Scientific Research
6.3.2. Medical
6.3.3. Industrial
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Stable Isotope Labeled Biomolecules Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Stable Isotope Labeled Biomolecules Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Stable Isotope Labeled Biomolecules Demand Share Forecast, 2019-2026
9. North America Stable Isotope Labeled Biomolecules Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Application
9.4.1. Scientific Research
9.4.2. Medical
9.4.3. Industrial
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Type
9.7.1. D Labeled Biomolecules
9.7.2. 15N Labeled Biomolecules
9.7.3. 13C Labeled Biomolecules
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Stable Isotope Labeled Biomolecules Demand Share Forecast, 2019-2026
10. Latin America Stable Isotope Labeled Biomolecules Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Application
10.4.1. Scientific Research
10.4.2. Medical
10.4.3. Industrial
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Type
10.7.1. D Labeled Biomolecules
10.7.2. 15N Labeled Biomolecules
10.7.3. 13C Labeled Biomolecules
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Stable Isotope Labeled Biomolecules Demand Share Forecast, 2019-2026
11. Europe Stable Isotope Labeled Biomolecules Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Application
11.4.1. Scientific Research
11.4.2. Medical
11.4.3. Industrial
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Type
11.7.1. D Labeled Biomolecules
11.7.2. 15 Labeled Biomolecules
11.7.3. 13C Labeled Biomolecules
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Stable Isotope Labeled Biomolecules Demand Share, 2019-2026
12. Asia Pacific Stable Isotope Labeled Biomolecules Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Application
12.4.1. Scientific Research
12.4.2. Medical
12.4.3. Industrial
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Type
12.7.1. D Labeled Biomolecules
12.7.2. 15N Labeled Biomolecules
12.7.3. 13C Labeled Biomolecules
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Stable Isotope Labeled Biomolecules Demand Share, 2019-2026
13. Middle East & Africa Stable Isotope Labeled Biomolecules Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Application
13.4.1. Scientific Research
13.4.2. Medical
13.4.3. Industrial
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Stable Isotope Labeled Biomolecules Market Size and Volume Forecast by Type
13.7.1. D Labeled Biomolecules
13.7.2. 15N Labeled Biomolecules
13.7.3. 13C Labeled Biomolecules
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Stable Isotope Labeled Biomolecules Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Stable Isotope Labeled Biomolecules Market: Market Share Analysis
14.2. Stable Isotope Labeled Biomolecules Distributors and Customers
14.3. Stable Isotope Labeled Biomolecules Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cambridge Isotope Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sigma-Aldrich
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LGC Standards
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Toronto Research Chemicals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. IsoLife
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. WITEGA Laboratorien
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Omicron Biochemicals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Icon Isotopes
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medical Isotopes
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook